Loading
This study tests a PARP inhibitor; the registry reports that it is not yet recruiting.
The registry lists NCT07832630 as not yet recruiting, last updated 2026-09-22. Enrolment is 124 planned participants, an estimate. Interventions: Saruparib, FoundationOne®CDx. Primary measures include Best objective response as determined by RECIST v.1.1. No results are posted in the registry; this does not exclude separate publications.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/